Observational study of obstructive lung disease (NOVELTY) - NOVELTY

Study identifier:D2287R00103

ClinicalTrials.gov identifier:NCT02760329

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A NOVEL observational longiTudinal studY on patients with asthma and/or COPD to describe patient characteristics, treatment patterns and the burden of illness over time and to identify phenotypes and endotypes.

Medical condition

asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

12255

Study type

Observational

Age

12 Years - 130 Years

Date

Study Start Date: 25 Jul 2016
Primary Completion Date: 31 May 2023
Study Completion Date: 31 May 2023

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Oct 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

PAREXEL

Inclusion and exclusion criteria